PTEN and neoplasm: Taken together, the PPV for MMR proficiency of PTEN-retained IHC ranged from 95% to 100%, suggesting that PTEN analysis can help in MMR status assessment, overcoming the bias represented by MMR intra-tumor heterogeneity.